资源描述：
《阿比特龙或恩杂鲁胺治疗晚期去势抵抗性前列腺癌：间接比较》由会员上传分享，免费在线阅读，更多相关内容在教育资源-天天文库。
1、阿比特龙或恩杂鲁胺治疗晚期去势抵抗性前列腺癌：间接比较TheProstateAbirateroneorEnzalutamideinAdvancedCastration-ResistantProstateCancer:AnIndirectComparisonAkhilChopra,1*MinaGeorgieva,2GilbertoLopes,3ChongMingYeo,1andBenjaminHaaland21DepartmentofMedicalOncology,JohnsHopkinsSingaporeInternationalMedicalCentre,Singapor
2、e2H.MiltonStewartSchoolofIndustrialandSystemsEngineering,GeorgiaInstituteofTechnology,Georgia3SylvesterComprehensiveCancerCenter,UniversityofMiami,Miami,FloridaBACKGROUND.Toperformacomparativeeffectivenessanalysesbetweenenzalutamideandabirateroneacetateinboththepre-docetaxelandpost-docetax
3、elsettingsbasedonpublishedphaseIIIrandomizedtrials.—————————————————————————————————————————————————————阿比特龙或恩杂鲁胺治疗晚期去势抵抗性前列腺癌：间接比较TheProstateAbirateroneorEnzalutamideinAdvancedCastration-ResistantProstateCancer:AnIndirectComparisonAkhilChopra,1*MinaGeorgieva,2GilbertoLopes,3ChongMingYeo,1
4、andBenjaminHaaland21DepartmentofMedicalOncology,JohnsHopkinsSingaporeInternationalMedicalCentre,Singapore2H.MiltonStewartSchoolofIndustrialandSystemsEngineering,GeorgiaInstituteofTechnology,Georgia3SylvesterComprehensiveCancerCenter,UniversityofMiami,Miami,FloridaBACKGROUND.Toperformacompa
5、rativeeffectivenessanalysesbetweenenzalutamideandabirateroneacetateinboththepre-docetaxelandpost-docetaxelsettingsbasedonpublishedphaseIIIrandomizedtrials.—————————————————————————————————————————————————————阿比特龙或恩杂鲁胺治疗晚期去势抵抗性前列腺癌：间接比较TheProstateAbirateroneorEnzalutamideinAdvancedCastratio
6、n-ResistantProstateCancer:AnIndirectComparisonAkhilChopra,1*MinaGeorgieva,2GilbertoLopes,3ChongMingYeo,1andBenjaminHaaland21DepartmentofMedicalOncology,JohnsHopkinsSingaporeInternationalMedicalCentre,Singapore2H.MiltonStewartSchoolofIndustrialandSystemsEngineering,GeorgiaInstituteofTechnol
7、ogy,Georgia3SylvesterComprehensiveCancerCenter,UniversityofMiami,Miami,FloridaBACKGROUND.Toperformacomparativeeffectivenessanalysesbetweenenzalutamideandabirateroneacetateinboththepre-docetaxelandpost-docetaxelsettingsbasedonpublishedphaseIIIrandomizedtrials.—
